PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany. fmarx@sun.ac.za.\', \'Department of Paediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. fmarx@sun.ac.za.\', \'DSI-NRF South African Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa. fmarx@sun.ac.za.\', \'Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany.\', \'Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, USA.\', \'Immunization Unit, Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12889-021-12142-4
?:hasPublicationType
?:journal
  • BMC public health
is ?:pmid of
?:pmid
?:pmid
  • 34836526
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.337
?:rankingScore_hIndex
  • 103
?:title
  • Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all